--- title: "301126.SZ (301126.SZ) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/301126.SZ/news.md" symbol: "301126.SZ" name: "301126.SZ" parent: "https://longbridge.com/en/quote/301126.SZ.md" datetime: "2026-03-09T07:11:46.107Z" locales: - [en](https://longbridge.com/en/quote/301126.SZ/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/301126.SZ/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/301126.SZ/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301126.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301126.SZ/news.md) # 301126.SZ (301126.SZ) — Related News ### [DAJIAWEIKANG: Shareholder Changsha Tongjia plans to reduce holdings by no more than 3%](https://longbridge.com/en/news/275116775.md) *2026-02-06T11:18:18.000Z* > DAJIAWEIKANG announced that its controlling shareholder and actual controller Wang Yiqing's concerted actor, Changsha To ### [Most of the biotechnology vaccine sector has retreated, with SSSW and DAJIAWEIKANG falling over 10%](https://longbridge.com/en/news/273770742.md) *2026-01-27T01:43:37.000Z* > Most of the biotechnology vaccine sector has retreated, with SSSW and DAJIAWEIKANG falling over 10%, WONDFO BIOTECH drop ### [DAJIAWEIKANG expects a pre-loss, with an estimated net loss attributable to the parent company of 250 million to 300 million yuan for the fiscal year 2025](https://longbridge.com/en/news/273698363.md) *2026-01-26T12:12:03.000Z* > DAJIAWEIKANG expects the net loss attributable to the parent company for the fiscal year 2025 to reach between 250 milli ### [A-share midday review: Shanghai Composite Index fluctuated and closed down 0.07%, pharmaceutical retail sector weakened again](https://longbridge.com/en/news/271168273.md) *2025-12-31T03:39:44.000Z* > The three major A-share indices collectively fell in early trading, with the Shanghai Composite Index experiencing narro ### [](https://longbridge.com/en/news/270952566.md) *2025-12-29T05:13:19.000Z* > A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, ### [](https://longbridge.com/en/news/270938822.md) *2025-12-29T01:50:02.000Z* > The A-share pharmaceutical commercial sector weakened at the beginning of trading, with SYPM falling over 15%, HRPC drop ### [SPD concept explodes, 4 stocks hit the daily limit! The transformation of the pharmaceutical supply chain accelerates, and policies support the launch of a trillion-yuan market](https://longbridge.com/en/news/270094346.md) *2025-12-18T02:38:40.000Z* > The SPD concept sector performed actively in the morning session, with 4 stocks hitting the daily limit. The demand for ### [](https://longbridge.com/en/news/270087639.md) *2025-12-18T01:34:17.000Z* > The A-share pharmaceutical sector strengthened at the beginning of the trading session, with Huaren Health rising over 1 ### [](https://longbridge.com/en/news/269666683.md) *2025-12-15T05:02:37.000Z* > The A-share pharmaceutical commercial sector saw a short-term surge, with CQP previously hitting the daily limit, DAJIAW ### [DAJIAWEIKANG: Shareholder Zhong Xuesong terminates the reduction plan early, with a total reduction of 1%](https://longbridge.com/en/news/266698186.md) *2025-11-20T09:20:55.000Z* > DAJIAWEIKANG announced that major shareholder and director Zhong Xuesong, who holds more than 5% of the shares, original